Pharmaceutical composition comprising adrenaline
US11957647B2 · kind B2 · utility
2Cited by
20References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 24, 2023 |
| Grant date | Apr 16, 2024 |
| Priority date | — |
| Expiry date | May 24, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2210/0618
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a pharmaceutically-acceptable composition in the form of a solid, amorphous, mono-particulate powder comprising a mixture of:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.